Clinica Universidad Navarra

Pamplona, Navarre 31008

3 studies enrolling now · 13 studies all time

What they study most

Autologous Stem Cell Transplant, Cholangiocarcinoma, Dravet Syndrome, Dravet Syndrome (DS), Epilepsy, Glioma, H3 K27M, Lennox Gastaut Syndrome (LGS), Lennox-Gastaut Syndrome, Lennox-Gastaut Syndrome (LGS), Metastatic or Unresectable Cutaneous Melanoma, Multiple Myeloma

Studies at this site

• Neoadjuvant Darovasertib in Primary Uveal Melanoma — Recruiting now
• ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) — Recruiting now
• Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer — Recruiting now
• A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome — Stopped early
• A Study of Soticlestat in Adults and Children With Rare Epilepsies — Stopped early
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
• A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome — Completed
• A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) — Completed
• PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer — Stopped early
• KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer — Stopped early
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies — Completed
• SYL040012, Treatment for Open Angle Glaucoma — Completed